David J Ross
Overview
Explore the profile of David J Ross including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
2202
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodriguez D, Edgar A, Williams D, Chov A, Vodnik D, Ross D, et al.
ACS Appl Mater Interfaces
. 2023 Jun;
15(23):28649-28663.
PMID: 37265007
Chemical solution deposition (CSD) methods involving the thermal decomposition of 5.0 M Er(NO)·5HO and Y(NO)·6HO precursor solutions were employed to fabricate protective erbia and yttria coatings onto stainless steel (SS304/SS316)...
2.
Bertero T, Lu Y, Annis S, Hale A, Bhat B, Saggar R, et al.
J Clin Invest
. 2022 May;
132(10).
PMID: 35575096
No abstract available.
3.
Rosenheck J, Ross D, Botros M, Wong A, Sternberg J, Chen Y, et al.
Transplant Direct
. 2022 Apr;
8(4):e1317.
PMID: 35372675
Background: Lung transplant patients are vulnerable to various forms of allograft injury, whether from acute rejection (AR) (encompassing acute cellular rejection [ACR] and antibody-mediated rejection [AMR]), chronic lung allograft dysfunction...
4.
Saggar R, Giri P, Deng C, Johnson D, McCloy M, Liang L, et al.
Pulm Circ
. 2021 May;
11(2):20458940211011329.
PMID: 33996029
The association of autoimmune disease (AI) with transplant-free survival in the setting of Group 3 pulmonary hypertension and pulmonary fibrosis remains unclear. We report cases of severe pulmonary hypertension (mean...
5.
Khush K, De Vlaminck I, Luikart H, Ross D, Nicolls M
ERJ Open Res
. 2021 Feb;
7(1).
PMID: 33532456
Surveillance after lung transplantation is critical to the detection of acute cellular rejection (ACR) and prevention of chronic lung allograft dysfunction (CLAD). Therefore, we measured donor-derived cell-free DNA (dd-cfDNA) implementing...
6.
Potter S, Hinojosa R, Miles C, OBrien D, Ross D
Kidney Res Clin Pract
. 2020 Dec;
39(4):495-500.
PMID: 33303727
Background: Donor-derived, cell-free DNA (dd-cfDNA) level correlates with allograft injury with clinical validity and utility for quiescence and active acute rejection (AR) in kidney transplant recipients. We analyzed trends in...
7.
Sayah D, Samuel Weigt S, Ramsey A, Ardehali A, Golden J, Ross D
Transplant Direct
. 2020 Oct;
6(10):e608.
PMID: 33062841
Methods: dd-cfDNA levels determined in biorepository venous plasma samples obtained during the lung allograft rejection gene expression observation study, implementing a clinical-grade next-generation sequencing assay. Sixty-nine unique LT patients encompassing...
8.
Levine D, Ross D, Sako E
Biomark Insights
. 2020 Sep;
15:1177271920958704.
PMID: 32982146
No abstract available.
9.
Seki A, Anklesaria Z, Saggar R, Dodson M, Schwab K, Liu M, et al.
ACR Open Rheumatol
. 2019 Nov;
1(1):26-36.
PMID: 31777777
Objective: We sought to determine if any histopathologic component of the pulmonary microcirculation can distinguish systemic sclerosis (SSc)-related pulmonary fibrosis (PF) with and without pulmonary hypertension (PH). Methods: Two pulmonary...
10.
Mallavia B, Liu F, Lefrancais E, Cleary S, Kwaan N, Tian J, et al.
Am J Respir Cell Mol Biol
. 2019 Oct;
62(3):364-372.
PMID: 31647878
The immune system is designed to robustly respond to pathogenic stimuli but to be tolerant to endogenous ligands to not trigger autoimmunity. Here, we studied an endogenous damage-associated molecular pattern,...